Latest medicinal cannabis News | Page 2

Health bodies urge crackdown on rogue operators as medicinal cannabis use jumps 5455% in five years
Dispensed Pty Ltd issued infringement notices and directed to cease alleged unlawful advertising of medicinal cannabis
Interstate Prescribing Bill Tabled In Parliament
Medicinal cannabis is most often prescribed for pain, anxiety and sleep. Here’s what the evidence says
AMA President’s update: AI report, medicinal cannabis, Indigenous health and a productivity roundtable
AMA welcomes consultation on unapproved medicinal cannabis
AMA President’s Update: And That’s Wrap For AMA25!
Planned consultation to address growing safety concerns of unapproved medicinal cannabis products in Australia
Managing anxiety in adults with autism: clinical trial recruiting now
Sex expression research looks to boost hempseed yields and supercharge production
Confusing for doctors, inequitable for patients: why Australia’s medicinal cannabis system needs urgent reform
AMA welcomes updated guidance on medicinal cannabis prescribing
What is cannabis use disorder? And how do you know if you have a problem?
Cannabinoid products may reduce total sleep time in adults with insomnia: new study
Medicinal cannabis is big business. But the latest clampdown won’t curb unsafe prescribing
More women are using medical cannabis – but new research shows barriers push some into illegal markets
New standards for nicotine vaping products from July 2025
Robust regulation needed to tackle medicinal cannabis prescribing
More people are trying medicinal cannabis for chronic pain. But does it work?
What are ‘penjamins’? Disguised cannabis vapes are gaining popularity among young people
Wednesday 23 April
Summit Pharmacy Pty Ltd issued infringement notices for the alleged unlawful manufacturing of medicinal cannabis products
Australian research reveals medicinal cannabis delivers long-term relief for a wide range of chronic conditions
No Excuse for Minns to Not Act on Politically Palatable Drug Summit Report Recommendations
Consultation opens on plans to change interstate prescribing laws
New electronic system to support pharmacy efficiency
Friday 28 February
LGP Welcomes Transformative Changes to Medicinal Cannabis Access in WA
Forum highlights University role in natural product development
‘Sleepy cannabis’: first objective study to show cannabinol increases sleep
Swinburne Medical Cannabis Driving Trial Starts
Medicinal Cannabis Driving Trial Starts
VIC medicinal cannabis driving law amendment overdue but welcome
Is Cannabis Answer To Insomnia?
Are sports stars who are caught using illegal drugs unfairly vilified?
Mater launches cannabis trial for regional palliative patients
Bioxyne (ASX:BXN) Delivers Australia’s First Pharmaceutical Cannabis Gummies Under TGA GMP Licence
AMA Meets With Ahpra And Medical Board
Southern Cross University announces $10 million gift from Blackmore Family Foundation
Inquiry backs AMA calls regarding risk of legalising cannabis for recreational use
Better Leaf Pty Ltd fined for alleged unlawful advertising of medicinal cannabis
Green Light For World-First Medicinal Cannabis Driving Trial
Dolphins agree to remove medicinal cannabis clinic branding from NRL games
All medicinal cannabis products supplied to Australian patients must meet quality standards
Court proceedings initiated against Montu Group Pty Ltd, Alternaleaf Pty Ltd, and an individual for alleged unlawful advertising of medicinal cannabis
Medicinal cannabis company Little Green Pharma (ASX:LGP) records record quarterly revenue and cash receipts
Referring To Cosmetic Injectables In Advertising
Consultation to remove glucagon-like-peptide-1 (GLP-1) receptor agonist analogues from the pharmacist extemporaneous compounding exemption